Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
35,616,666
-
Shares change
-
+1,298,626
-
Total reported value, excl. options
-
$422,040,218
-
Value change
-
+$16,175,615
-
Put/Call ratio
-
50%
-
Number of buys
-
38
-
Number of sells
-
36
-
Price
-
$11.85
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q3 2017
As of 30 Sep 2017 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 35,616,666 shares of stock of the company.
Largest 10 holders included FMR LLC, BRIDGER MANAGEMENT, LLC, BlackRock Inc., STATE STREET CORP, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, COLUMBUS CIRCLE INVESTORS, JENNISON ASSOCIATES LLC, UBS ASSET MANAGEMENT AMERICAS INC, and SENZAR ASSET MANAGEMENT, LLC.
This table shows 122 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.